Conventional structural magnetic resonance imaging (MRI) features, including glioma location, glioma volume, necrosis, invasiveness, enhancement pattern, and peritumoral edema, have been used to predict the IDH, MGMT, and TERT status [5–8], however with controversies. This evidence concerns the gene MGMT and glioma.